Edition:
United States

People: Amgen Inc (AMGN.O)

AMGN.O on Nasdaq

186.28USD
18 Oct 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$186.28
Open
--
Day's High
--
Day's Low
--
Volume
550
Avg. Vol
2,799,453
52-wk High
$191.10
52-wk Low
$133.64

Baltimore, David 

Dr. David Baltimore, Ph.D., is an Independent Director of Amgen Inc. David Baltimore is President Emeritus and Robert Andrews Millikan Professor of Biology at the California Institute of Technology, or Caltech. He received the Nobel Prize in Medicine as a co-recipient in 1975. Dr. Baltimore has been a director of Regulus Therapeutics Inc., a biopharmaceutical company, since 2007, serving on its Compensation Committee and chairing its Nominating and Governance Committee, and is a member of its scientific advisory board. Dr. Baltimore has also been a member of the board of directors of Immune Design Corp. (formerly Vaccsys), a clinical-stage immunotherapy company, since 2008, chairing its Nominating and Governance Committee, and is a member of its scientific advisory board. He was a director of BB Biotech, AG, a Swiss investment company, from 1994 to March 2011 and served as a director of MedImmune, Inc., a privately-held antibody formulation company, from 2003 until its acquisition by AstraZeneca plc, a pharmaceutical and biotechnology company, in 2007. In 2008, Dr. Baltimore became a founder of Calimmune, Inc., a privately-held clinical-stage gene therapy company, and served as Chairman of the board of directors until November 2015.

Basic Compensation

Total Annual Compensation, USD 124,000
Restricted Stock Awards, USD 199,972
Long-Term Incentive Plans, USD --
All Other, USD 24,986
Fiscal Year Total, USD 348,958

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Bradway

16,850,000

David Meline

6,218,460

Sean Harper

6,213,040

Anthony Hooper

6,965,180

Brian McNamee

--

Esteban Santos

--
As Of  30 Dec 2016